1. Potentilla fulgens upregulate GLUT4, AMPK, AKT and insulin in alloxan-induced diabetic mice: an in vivo and in silico study.
- Author
-
Thabah D, Syiem D, Pakyntein CL, Banerjee S, Kharshiing CE, and Bhattacharjee A
- Subjects
- Mice, Animals, Insulin metabolism, Proto-Oncogene Proteins c-akt metabolism, AMP-Activated Protein Kinases genetics, AMP-Activated Protein Kinases metabolism, Alloxan pharmacology, Plant Extracts pharmacology, Plant Extracts chemistry, Molecular Docking Simulation, Glucose Transporter Type 4 genetics, Muscle, Skeletal metabolism, Potentilla chemistry, Potentilla metabolism, Diabetes Mellitus, Experimental drug therapy, Diabetes Mellitus, Experimental metabolism, Catechin pharmacology
- Abstract
Objective: This study was designed to investigate whether the glucose lowering effects of Potentilla fulgens acts by modulating GLUT4, AKT2 and AMPK expression in the skeletal muscle and liver tissues., Methodology: Alloxan-induced diabetic mice treated with Potentilla fulgens was assessed for their blood glucose and insulin level, mRNA and protein expression using distinguished methods. Additionally, GLUT4, AKT2 and AMPK were docked with catechin, epicatechin, kaempferol, metformin, quercetin and ursolic acid reportedly present in Potentilla fulgens ., Results: Potentilla fulgens ameliorates hyperglycaemia and insulin sensitivity via activation of AKT2 and AMPK, increases the expression of GLUT4, AKT2, AMPKα1 and AMPKα2 whose levels are reduced under diabetic condition. Molecular docking revealed interacting residues and their binding affinities (-4.56 to -8.95 Kcal/mol)., Conclusions: These findings provide more clarity vis-avis the mechanism of action of the phytoceuticals present in Potentilla fulgens extract which function through their action on GLUT4, PKB and AMPK.
- Published
- 2023
- Full Text
- View/download PDF